Phillip Durham

Phillip Durham is a Research Assistant Professor in the Department of Biomedical Engineering at the University of North Carolina at Chapel Hill. His work focuses on advancing medical imaging and therapeutic delivery systems, particularly in overcoming biological barriers like the blood-brain barrier and biofilms. He specializes in ultrasound-based technologies, nanomedicine, and aerosol drug delivery.

Research interests include ultrasound contrast agents, targeted drug delivery, and infectious disease treatments (e.g., tuberculosis, MRSA). His lab develops novel methods for noninvasive imaging and treatment of conditions like glioblastoma, liver disease, and diabetic wounds. He has pioneered phase-change nanodroplet systems and AI-driven diagnostic tools for animal models.

His recent work emphasizes therapeutic ultrasound applications, including automated liver sizing algorithms and inhalable contrast agents. These innovations aim to improve treatment efficacy while reducing invasiveness. Key projects involve collaborations across engineering, medicine, and materials science disciplines.

While no specific awards are listed, his research has been featured in high-impact journals and conferences, reflecting its methodological and translational significance. His work directly impacts preclinical models, with potential for clinical application in oncology, neurology, and infectious disease management.